10.65
-0.76
(-6.66%)
At close: 4:00:01 PM EDT
10.66
+0.01
+(0.09%)
After hours: 4:17:25 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 314,332 | 17 |
| Sales | 56,784 | 3 |
| Net Shares Purchased (Sold) | 257,548 | 20 |
| Total Insider Shares Held | 595.54k | -- |
| % Net Shares Purchased (Sold) | 76.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| NOVACK DAVID F President | Sale at price 14.00 per share. | Direct | 140,000 | Mar 24, 2025 |
| NOVACK DAVID F President | Conversion of Exercise of derivative security at price 6.80 per share. | Direct | 68,050 | Mar 24, 2025 |
| NOVACK DAVID F President | Sale at price 13.58 per share. | Direct | 190,392 | Mar 18, 2025 |
| NOVACK DAVID F President | Sale at price 14.39 per share. | Direct | 471,474 | Mar 7, 2025 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 18, 2025 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 18, 2025 |
| MACDONALD KELLY Chief Financial Officer | -- | Direct | -- | Feb 18, 2025 |
| SLEBIR JOHN L General Counsel | -- | Direct | -- | Feb 18, 2025 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 18, 2025 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 13, 2025 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 13, 2025 |
| MACDONALD KELLY Chief Financial Officer | -- | Direct | -- | Feb 13, 2025 |
| SLEBIR JOHN L General Counsel | -- | Direct | -- | Feb 13, 2025 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 13, 2025 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 10, 2025 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 10, 2025 |
| MACDONALD KELLY Chief Financial Officer | -- | Direct | -- | Feb 10, 2025 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 10, 2025 |
| SLEBIR JOHN L General Counsel | -- | Direct | -- | Feb 10, 2025 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 10, 2025 |
| CANO FRANCIS R. PH.D. Director | Sale at price 11.93 per share. | Direct | 43,127 | May 31, 2024 |
| CANO FRANCIS R. PH.D. Director | Conversion of Exercise of derivative security at price 5.90 per share. | Direct | 44,250 | May 24, 2024 |
| KISNER DANIEL L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| PHILLIPS PEGGY V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| CANO FRANCIS R. PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| MYERS SCOTT DUNSETH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| EASTLAND JULIA MARIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| SUN ELAINE D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| MACGREGOR BRENT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| PARADISO PETER R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| BURGESS JUSTIN Officer | Sale at price 12.78 per share. | Direct | 262,322 | Mar 1, 2024 |
| BURGESS JUSTIN Officer | Conversion of Exercise of derivative security at price 9.41 - 11.12 per share. | Direct | 74,232 | Mar 1, 2024 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 16, 2024 |
| NOVACK DAVID F President | Stock Award(Grant) at price 12.48 per share. | Direct | 15,063 | Feb 15, 2024 |
| SPENCER RYAN Chief Executive Officer | Stock Award(Grant) at price 12.48 per share. | Direct | 5,017 | Feb 15, 2024 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 9, 2024 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 9, 2024 |
| MACDONALD KELLY Chief Financial Officer | -- | Direct | -- | Feb 9, 2024 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 9, 2024 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 9, 2024 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 2, 2024 |
| JANSSEN ROBERT Officer | -- | Direct | -- | Feb 2, 2024 |
| SPENCER RYAN Chief Executive Officer | -- | Direct | -- | Feb 2, 2024 |
| BURGESS JUSTIN Officer | -- | Direct | -- | Feb 2, 2024 |
| NOVACK DAVID F President | -- | Direct | -- | Feb 2, 2024 |
| JANSSEN ROBERT Officer | Sale at price 15.00 per share. | Direct | 22,500 | Jan 4, 2024 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security at price 9.41 per share. | Direct | 14,115 | Jan 4, 2024 |
| NOVACK DAVID F Chief Operating Officer | Sale at price 14.45 per share. | Direct | 130,050 | Jan 2, 2024 |
| NOVACK DAVID F Chief Operating Officer | Conversion of Exercise of derivative security at price 5.42 per share. | Direct | 48,780 | Jan 2, 2024 |
| NOVACK DAVID F President | Sale at price 13.56 per share. | Direct | 271,200 | Dec 1, 2023 |
Related Tickers
COLL Collegium Pharmaceutical, Inc.
27.02
-0.37%
BCRX BioCryst Pharmaceuticals, Inc.
7.22
-2.43%
PCRX Pacira BioSciences, Inc.
24.47
-1.65%
ESPR Esperion Therapeutics, Inc.
0.9639
-3.19%
ALKS Alkermes plc
27.20
-2.65%
SCYX SCYNEXIS, Inc.
0.9126
-0.39%
AVDL Avadel Pharmaceuticals plc
8.15
+3.03%
AKBA Akebia Therapeutics, Inc.
1.9000
+0.53%
EBS Emergent BioSolutions Inc.
4.6200
-0.22%
SIGA SIGA Technologies, Inc.
5.92
-1.99%